Annual Accounts Receivable
$26.18 M
+$4.85 M+22.76%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual accounts receivable is $26.18 million, with the most recent change of +$4.85 million (+22.76%) on December 31, 2023.
- During the last 3 years, OCUL annual accounts receivable has risen by +$13.93 million (+113.67%).
- OCUL annual accounts receivable is now at all-time high.
Performance
OCUL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$30.23 M
+$3000.00+0.01%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly accounts receivable is $30.23 million, with the most recent change of +$3000.00 (+0.01%) on September 30, 2024.
- Over the past year, OCUL quarterly accounts receivable has increased by +$6.65 million (+28.17%).
- OCUL quarterly accounts receivable is now at all-time high.
Performance
OCUL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
OCUL Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.8% | +28.2% |
| 3 y3 years | +113.7% | +54.6% |
| 5 y5 years | +10000.0% | +2614.1% |
OCUL Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.9% | at high | +52.7% |
| 5 y | 5-year | at high | +927.4% | at high | +1086.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Ocular Therapeutix Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $30.23 M(+0.0%) |
| Jun 2024 | - | $30.23 M(+13.9%) |
| Mar 2024 | - | $26.55 M(+1.4%) |
| Dec 2023 | $26.18 M(+22.8%) | $26.18 M(+11.0%) |
| Sep 2023 | - | $23.59 M(-13.6%) |
| Jun 2023 | - | $27.31 M(+29.3%) |
| Mar 2023 | - | $21.12 M(-0.9%) |
| Dec 2022 | $21.32 M(+0.9%) | $21.32 M(+7.7%) |
| Sep 2022 | - | $19.80 M(-3.3%) |
| Jun 2022 | - | $20.48 M(-11.7%) |
| Mar 2022 | - | $23.21 M(+9.8%) |
| Dec 2021 | $21.14 M(+72.5%) | $21.14 M(+8.1%) |
| Sep 2021 | - | $19.55 M(+4.4%) |
| Jun 2021 | - | $18.73 M(+37.4%) |
| Mar 2021 | - | $13.63 M(+11.3%) |
| Dec 2020 | $12.25 M(+380.8%) | $12.25 M(+57.5%) |
| Sep 2020 | - | $7.78 M(+170.7%) |
| Jun 2020 | - | $2.87 M(-16.2%) |
| Mar 2020 | - | $3.43 M(+34.6%) |
| Dec 2019 | $2.55 M | $2.55 M(+128.7%) |
| Sep 2019 | - | $1.11 M(+81.1%) |
| Jun 2019 | - | $615.00 K(+122.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $276.00 K(+37.3%) |
| Dec 2018 | $201.00 K(-11.1%) | $201.00 K(-16.3%) |
| Sep 2018 | - | $240.00 K(-15.8%) |
| Jun 2018 | - | $285.00 K(+67.6%) |
| Mar 2018 | - | $170.00 K(-24.8%) |
| Dec 2017 | $226.00 K(-9.6%) | $226.00 K(-18.7%) |
| Sep 2017 | - | $278.00 K(+31.8%) |
| Jun 2017 | - | $211.00 K(-13.5%) |
| Mar 2017 | - | $244.00 K(-2.4%) |
| Dec 2016 | $250.00 K(+29.5%) | $250.00 K(+2.9%) |
| Sep 2016 | - | $243.00 K(+9.0%) |
| Jun 2016 | - | $223.00 K(-1.8%) |
| Mar 2016 | - | $227.00 K(+17.6%) |
| Dec 2015 | $193.00 K(-41.3%) | $193.00 K(+2.1%) |
| Sep 2015 | - | $189.00 K(+15.2%) |
| Jun 2015 | - | $164.00 K(-53.4%) |
| Mar 2015 | - | $352.00 K(+7.0%) |
| Dec 2014 | $329.00 K(+22.3%) | $329.00 K(+509.3%) |
| Sep 2014 | - | $54.00 K(-11.5%) |
| Jun 2014 | - | $61.00 K(-80.1%) |
| Mar 2014 | - | $306.00 K(+13.8%) |
| Dec 2013 | $269.00 K(+497.8%) | $269.00 K |
| Dec 2012 | $45.00 K | - |
FAQ
- What is Ocular Therapeutix annual accounts receivable?
- What is the all time high annual accounts receivable for Ocular Therapeutix?
- What is Ocular Therapeutix annual accounts receivable year-on-year change?
- What is Ocular Therapeutix quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly accounts receivable year-on-year change?
What is Ocular Therapeutix annual accounts receivable?
The current annual accounts receivable of OCUL is $26.18 M
What is the all time high annual accounts receivable for Ocular Therapeutix?
Ocular Therapeutix all-time high annual accounts receivable is $26.18 M
What is Ocular Therapeutix annual accounts receivable year-on-year change?
Over the past year, OCUL annual accounts receivable has changed by +$4.85 M (+22.76%)
What is Ocular Therapeutix quarterly accounts receivable?
The current quarterly accounts receivable of OCUL is $30.23 M
What is the all time high quarterly accounts receivable for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly accounts receivable is $30.23 M
What is Ocular Therapeutix quarterly accounts receivable year-on-year change?
Over the past year, OCUL quarterly accounts receivable has changed by +$6.65 M (+28.17%)